January 4, 2021
Tag: Jonathan Serody
December 31, 2020
United Press International: Study: Modified immunotherapy may work in advanced breast cancer
December 31, 2020
Study points the way to boosting immunotherapy effectiveness against breast cancer and other solid tumors
CAR-T therapy has proven effective for some blood cancers. New research by Jonathan S. Serody, MD, and colleagues suggests ways to use it effectively to attack solid tumors.
December 3, 2018
Study shows promise for fighting relapsed blood cancer with CAR-T immunotherapy, chemotherapy
At the 60th American Society of Hematology Annual Meeting in San Diego on Monday, UNC Lineberger's Natalie Grover, MD, presented preliminary results from a clinical study of an investigational cellular immunotherapy for Hodgkin lymphoma and non-Hodgkin lymphoma expressing the CD30 protein marker.